Table 1 Clinico-demographic profile and hospital outcomes of 24,563 admitted COVID-19 patients during 1 year based on gender.
Total | Male | Female | P-value | |
|---|---|---|---|---|
Age | ||||
< 65 yr | 15,661(63.8) | 8366(34.2) | 7295(38.3) | |
≥ 65 yr | 8879(36.2) | 4354(65.8) | 4525(61.73) | < 0.001* |
COVID-19 History(yes) | 165(1.3) | 78(1.2) | 87(1.4) | 0.19 |
Exposure to the COVID-19 patient (yes) | 8533(34.7) | 4348(34.2) | 4185(35.4) | 0.045* |
The onset of the admission time(days) | 4.89 ± 6.38 | 4.96 ± 7.15 | 4.82 ± 5.41 | 0.07 |
Breath rate | ||||
14–18 | 5249(46.9) | 2735(46.9) | 2514(46.9) | |
18–22 | 4753(42.5) | 244(49.1) | 2309(43.1) | |
22–28 | 996(8.9) | 544(9.3) | 542(8.4) | |
≥ 28 | 189(1.7) | 104(1.8) | 85(1.6) | 0.25 |
Mean temperature-°C | 37.11 ± 0.74 | 37.12 ± 0.76 | 37.09 ± 0.72 | 0.01* |
Symptoms number (%) | ||||
Fever | 10,054(40.9) | 5341(42) | 4713(39.8) | 0.001* |
Cough | 11,046(45) | 5381(44.5) | 5381(45.5) | 0.12 |
Dyspnea | 11,009(44.8) | 5763(45.3) | 5246(44.3) | 0.14 |
Chest pain | 1078(4.8) | 518(4.4) | 560(5.2) | 0.007* |
Abdominal pain | 401(50.8) | 43(3.3) | 34(3.7) | 0.10* |
Nausea | 1541(6.7) | 759(6.4) | 782(7.1) | 0.023 |
Vomiting | 1203(5.3) | 588(4.9) | 615(5.6) | 0.024* |
Diarrhea | 818(3.6) | 429(3.6) | 389(3.5) | 0.8 |
Loss of appetite | 2284(10) | 1216(10.2) | 1068(9.7) | 0.22 |
Muscular. Pain | 6941(28.3) | 3467(27.2) | 3474(29.4) | < 0.001* |
Paresis | 152(0.7) | 89(0.8) | 63(0.6) | 0.17 |
Plegia | 79(0.4) | 49(0.4) | 30(0.3) | 0.07 |
Vertigo | 614(48.5) | 298(2.5) | 316(2.9) | 0.07 |
Seizure | 77(0.3) | 43(0.3) | 34(0.3) | 0.48 |
Insomnia | 380(1.5) | 189(1.5) | 191(1.6) | 0.41 |
Unconsciousness | 1170(4.8) | 642(5) | 528(4.5) | 0.03* |
Headache | 1824(8.1) | 913(7.8) | 911(8.4) | 0.07 |
Smell impairment | 380(1.5) | 189(1.5) | 191(1.6) | 0.41 |
Taste impairment | 225(0.9) | 20(0.9) | 105(0.9) | 0.65 |
Skin sign | 30(0.1) | 1(0.1) | 19(0.2) | 0.09 |
GI symptom | 4086(17.9) | 2102(17.1) | 1984(18.8) | 0.4 |
Respiratory symptom | 17,737(74.5) | 9221(74.6) | 8516(74.4) | 0.78 |
Nervous system | 223(0.9) | 119(0.9) | 104(0.9) | 0.6 |
Comorbidity | ||||
Cardiovascular disease | 2012(8.2) | 976(7.7) | 1036(8.8) | 0.002* |
Hypertension | 283(11.5) | 1157(9.1) | 1674(14.1) | < 0.001* |
Diabetes mellitus | 2853(11.6) | 1253(9.8) | 1600(13.5) | < 0.001* |
Cancer | 330(1.3) | 166(1.3) | 164(1.4) | 0.5 |
COPD (Chronic Obstructive Pulmonary Disease) | 504(2.1) | 293(2.3) | 211(1.8) | 0.004* |
CKD (chronic kidney disease) | 393(1.6) | 219(1.7) | 174(1.5) | 0.11 |
Asthma (N = 239) | 239(1) | 101(0.8) | 38(1.2) | 0.003* |
Liver disease (N = 49) | 49(0.2) | 30(61.2) | 19(38.8) | 0.18 |
Neurological disorders | 223(0.9) | 119(53.4) | 10,446.6) | 0.64 |
Hematology (N = 79) | 74(0.3) | 33(0.3) | 41(0.3) | 0.2 |
HIV (N = 13) | 13(0.1) | 7(0.1) | 6(0.1) | 0.8 |
Immunodeficiency disorders | ||||
Congenital disorder (N = 23) | 23(0.1) | 4(0) | 19(0.2) | 0.001* |
Smoking | 456(1.9) | 434(3.4) | 22(0.2) | < 0.001* |
Opium | 456(1.9) | 404(3.2) | 52(0.4) | < 0.001* |
PaO2 saturation % | ||||
93% > | 12,243(49.8) | 6361(50) | 5882(49.7) | |
93% ≤ | 12,320(50.2) | 6370(50) | 5950(50.3) | 0.69 |
Early diagnosis based on | ||||
Positive PCR | 9510(38.7) | 4824(37.9) | 4686(39.6) | |
Abnormal lung CT | 8016(32.7) | 4271(33.6) | 3745(31.7) | |
Clinically admission | 7023(28.6) | 3629(28.5) | 3394(28.7) | 0.003* |
Inpatients Treatments | ||||
Mechanical ventilation | 1213(4.9) | 665(5.2) | 548(4.6) | 0.03* |
Dialysis (N = 224/393) | 224(57) | 113(51.6) | 111(63.8) | 0.015 |
Oxygen therapy | 3949(31.2) | 2066(31.2) | 1883(31.2) | 0.9 |
Chemotherapy (N = 48) | 48(38.7) | 20(34.5) | 28(42.4) | 0.3 |
Severity | ||||
Yes | 2559(13.1) | 1398(13.6) | 1161(12.5) | |
No | 17,017(86.9) | 8893(86.4) | 8124(87.5) | 0.025* |
Hospital Outcome | ||||
Death | 2185(8.9) | 1184(9.3) | 1001(8.5) | |
Recovery | 22,378(91.1) | 11,547(90.7) | 10,831(91.5) | 0.02* |
Hospitalization length(days) | 4.89 ± 6.38 | 4.96 ± 7.15 | 4.82 ± 5.41 | 0.07 |
